Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

This study has been completed.
Sponsor:
Collaborator:
Health Research Fund of ISCIII Spain
Information provided by:
Gerencia De Atencion Primaria Area 2 De Madrid
ClinicalTrials.gov Identifier:
NCT01270022
First received: January 4, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
  Purpose

The aim of this study is to evaluate the impact of a clinical guideline in cardiovascular risk, with a local adaptation model of the existing guidelines in clinical practise at present, of each of the different cardiovascular risk factors, and the implementation strategy.


Condition Intervention
Cardiovascular Risk Factors
Clinical Practice Guideline
Implementation Strategies
Primary Care
Other: Implementation
Other: dissemination

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Health Services Research
Official Title: Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk.

Further study details as provided by Gerencia De Atencion Primaria Area 2 De Madrid:

Study Start Date: January 2004
Study Completion Date: July 2010
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Implementation Other: Implementation
Active Comparator: dissemination Other: dissemination

Detailed Description:

With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.

The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.

And the evaluation of the implementation strategy, used between the primary care physicians.

For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.

The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.

The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation.

  Eligibility

Ages Eligible for Study:   14 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients whose health cards showed them to belong to the studied health area

Exclusion Criteria:

  • Clinical history have not opened in the health center or this one is empty
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01270022

Locations
Spain
Gerencia de Atención Primaria del área 2
Madrid, Spain, 28009
Sponsors and Collaborators
Gerencia De Atencion Primaria Area 2 De Madrid
Health Research Fund of ISCIII Spain
Investigators
Principal Investigator: Blanca Novella, MD. pHD Gerencia de Atención Primaria del área 2
  More Information

No publications provided by Gerencia De Atencion Primaria Area 2 De Madrid

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Blanca Novella Arribas, Gerencia de Atención Primaria Area 2 Madrid
ClinicalTrials.gov Identifier: NCT01270022     History of Changes
Other Study ID Numbers: PI031216
Study First Received: January 4, 2011
Last Updated: January 4, 2011
Health Authority: Spain:Health Research Fund. ISCIII
Spain: Ethics Committee La Princesa Hospital
Spain: Ministry of Health

ClinicalTrials.gov processed this record on September 18, 2014